§ BIOTECHNOLOGY
USD · Biotechnology

GLUE

MONTE ROSA THERAPEUTICS INC
USDSector · BiotechnologyBeta · 1.34
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
114 increased/new, 62 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B4.38EPS (TTM)-1.74
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
NEA Management Company, LLC7.7M7.2%±0%
BlackRock, Inc.5.6M0.0%+35%
TCG Crossover Management, LLC4.6M2.2%±0%
BVF INC/IL4.5M2.3%+16%
BAKER BROS. ADVISORS LP4.3M0.4%±0%
MONTANOVA CAPITAL, LLC4.2M1.8%+26%
◇ AC INTELLIGENCE

Top institutional owners for GLUE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER88.7% · 128 holders
PASSIVE / INDEX10.9% · 8 holders
QUALITY / COMPOUNDER10.6% · 16 holders
DEALER / BANK9.4% · 18 holders
SYSTEMATIC / QUANT3.5% · 7 holders
TACTICAL / MACRO1.1% · 3 holders
INCOME / DEFENSIVE0.6% · 9 holders
GROWTH / MOMENTUM0.1% · 1 holder
ACTIVIST0.1% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for GLUE in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention GLUE yet.